Cargando…
Biosimilar Drugs for Psoriasis: Principles, Present, and Near Future
Psoriasis is a chronic, inflammatory, lifelong disease with a high prevalence (afflicting approximately 1–5% of the population worldwide) and is associated with significant morbidity. The introduction of biologic therapies has improved the management of this disease. Multiple biologic medicines that...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002312/ https://www.ncbi.nlm.nih.gov/pubmed/29549597 http://dx.doi.org/10.1007/s13555-018-0230-9 |